Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online December 15, 2005
Stem Cells Vol. 24 No. 4 April 2006, pp. 1128 -1136
doi:10.1634/stemcells.2005-0263; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0263v1
24/4/1128    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utsugisawa, T.
Right arrow Articles by Karlsson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utsugisawa, T.
Right arrow Articles by Karlsson, S.

TISSUE-SPECIFIC STEM CELLS

A Road Map Toward Defining the Role of Smad Signaling in Hematopoietic Stem Cells

Taiju Utsugisawaa, Jennifer L. Moodya, Marie Asplinga, Eva Nilssona, Leif Carlssonb, Stefan Karlssona

a Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine and The Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University Hospital, Lund, Sweden;
b Umeå Center for Molecular Medicine, Umeå University, Umeå, Sweden

Key Words. Hematopoietic stem cells • Smad signaling • Transforming growth factor-ß • Bone morphogenic proteins • Activin

Correspondence: Stefan Karlsson, M.D., Ph.D., Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine and The Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University Hospital, BMC A12, 221 84, Lund, Sweden. Telephone: 46-46-222-0577, Fax: 46-46-222-0568; e-mail: Stefan.Karlsson{at}molmed.lu.se

Received on June 14, 2005; accepted for publication on December 9, 2005.

The transforming growth factor-ß (TGF-ß) superfamily encompasses the ligands and receptors for TGF-ß, bone morphogenic proteins (BMPs), and Activins. Cellular response to ligand is context-dependent and may be controlled by specificity and/or redundancy of expression of these superfamily members. Several pathways within this family have been implicated in the proliferation, differentiation, and renewal of hematopoietic stem cells (HSCs); however, their roles and redundancies at the molecular level are poorly understood in the rare HSC. Here we have characterized the expression of TGF-ß superfamily ligands, receptors, and Smads in murine HSCs and in the Lhx2-hematopoietic progenitor cell (Lhx2-HPC) line. We demonstrate a remarkable likeness between these two cell types with regard to expression of the majority of receptors and Smads necessary for the transduction of signals from TGF-ß, BMP, and Activin. We have also evaluated the response of these two cell types to various ligands in proliferation assays. In this regard, primary cells and the Lhx2-HPC line behave similarly, revealing a suppressive effect of Activin-A that is similar to that of TGF-ß in bulk cultures and no effect of BMP-4 on proliferation. Signaling studies that verify the phosphorylation of Smad2 (Activin and TGF-ß) and Smad1/5 (BMP) confirm cytosolic responses to these ligands. In addition to providing a thorough characterization of TGF-ß superfamily expression in HSCs, our results define the Lhx2-HPC line as an appropriate model for molecular characterization of Smad signaling.




This article has been cited by other articles:


Home page
BloodHome page
N. C. Robson, D. J. Phillips, T. McAlpine, A. Shin, S. Svobodova, T. Toy, V. Pillay, N. Kirkpatrick, D. Zanker, K. Wilson, et al.
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production
Blood, March 1, 2008; 111(5): 2733 - 2743.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood, January 15, 2008; 111(2): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. L. Moody, S. Singbrant, G. Karlsson, U. Blank, M. Aspling, J. Flygare, D. Bryder, and S. Karlsson
Endoglin Is Not Critical for Hematopoietic Stem Cell Engraftment and Reconstitution but Regulates Adult Erythroid Development
Stem Cells, November 1, 2007; 25(11): 2809 - 2819.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. K. Kim, S. B. Song, K. I. Kang, M. Rhee, and K. E. Kim
Activation of the Thyroid-Stimulating Hormone {beta}-Subunit Gene by LIM Homeodomain Transcription Factor Lhx2
Endocrinology, July 1, 2007; 148(7): 3468 - 3476.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Karlsson, U. Blank, J. L. Moody, M. Ehinger, S. Singbrant, C.-X. Deng, and S. Karlsson
Smad4 is critical for self-renewal of hematopoietic stem cells
J. Exp. Med., March 19, 2007; 204(3): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, J. L. Moody, T. Utsugisawa, M. Magnusson, S. Singbrant, J. Larsson, and S. Karlsson
Smad7 promotes self-renewal of hematopoietic stem cells
Blood, December 15, 2006; 108(13): 4246 - 4254.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.